Abstract
Annual Review of Neuroscience
Vol. 26:
565-597
(Volume publication date March 2003)
(doi:10.1146/annurev.neuro.26.041002.131334)
First published online as a Review in Advance on April 18, 2003NOTCH AND PRESENILIN: Regulated Intramembrane Proteolysis Links Development and Degeneration Dennis Selkoe1 and Raphael Kopan21Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115; email: dselkoe@rics.bwh.harvard.edu 2Department of Molecular Biology and Pharmacology and Department of Medicine, Washington University, St. Louis, Missouri 63110; email: kopan@pcg.wustl.edu ▪ Abstract Intensive studies of three proteins—Presenilin, Notch, and the amyloid precursor protein (APP)—have led to the recognition of a direct intersection between early development and late-life neurodegeneration. Notch signaling mediates many different intercellular communication events that are essential for determining the fates of neural and nonneural cells during development and in the adult. The Notch receptor acts in a core pathway as a membrane-bound transcription factor that is released to the nucleus by a two-step cleavage mechanism called regulated intramembrane proteolysis (RIP). The second cleavage is effected by Presenilin, an unusual polytopic aspartyl protease that apparently cleaves Notch and numerous other single-transmembrane substrates within the lipid bilayer. Another Presenilin substrate, APP, releases the amyloid ß-protein that can accumulate over time in limbic and association cortices and help initiate Alzheimer's disease. Elucidating the detailed mechanism of Presenilin processing of membrane proteins is important for understanding diverse signal transduction pathways and potentially for treating and preventing Alzheimer's disease. Most recent citing papers (via CrossRef)Structural Basis for Self-Renewal of Neural Progenitors in Cortical Neurogenesis Cerebral Cortex 19(Supplement 1):i55-i61 (2009) Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal Nature Cell Biology 11(7):873-880 (2009) Variations in the neuropathology of familial Alzheimer’s disease Acta Neuropathologica 118(1):37-52 (2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Nature Reviews Neuroscience 10(5):333-344 (2009) Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL Blood 113(18):4381-4390 (2009)
|
|
|